These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11978143)

  • 1. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?
    Doherty MM; Charman WN
    Clin Pharmacokinet; 2002; 41(4):235-53. PubMed ID: 11978143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug metabolism in the small intestine--the significance for biological availability].
    Andersen VC; Sonne J
    Ugeskr Laeger; 2000 May; 162(22):3215-9. PubMed ID: 10850220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs.
    Galetin A; Hinton LK; Burt H; Obach RS; Houston JB
    Curr Drug Metab; 2007 Oct; 8(7):685-93. PubMed ID: 17979656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF
    Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and Enterotoxicity.
    Li AP; Alam N; Amaral K; Ho MD; Loretz C; Mitchell W; Yang Q
    Drug Metab Dispos; 2018 Nov; 46(11):1562-1571. PubMed ID: 30006371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
    Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions between food and drugs. 2. Disturbances of drug metabolism and synergistic mode of action].
    Jarosz M; Dzieniszewski J
    Pol Merkur Lekarski; 2000 Nov; 9(53):795-8. PubMed ID: 11204334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.
    Shen DD; Kunze KL; Thummel KE
    Adv Drug Deliv Rev; 1997 Sep; 27(2-3):99-127. PubMed ID: 10837554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
    Li AP
    Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
    Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans.
    Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
    J Pharm Sci; 2009 Nov; 98(11):4343-53. PubMed ID: 19230019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of intestinal first-pass drug metabolism.
    Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A
    Curr Drug Metab; 2007 Oct; 8(7):676-84. PubMed ID: 17979655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal drug transporters: an overview.
    Estudante M; Morais JG; Soveral G; Benet LZ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative metabolism of foreign compounds in rat small intestine: cellular localization and dependence on dietary iron.
    Hoensch H; Woo CH; Raffin SB; Schmid R
    Gastroenterology; 1976 Jun; 70(6):1063-70. PubMed ID: 817959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions.
    Galetin A; Gertz M; Houston JB
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):909-22. PubMed ID: 18624679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans.
    Darwich AS; Aslam U; Ashcroft DM; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Dec; 42(12):2016-22. PubMed ID: 25233858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations.
    van de Kerkhof EG; Ungell AL; Sjöberg AK; de Jager MH; Hilgendorf C; de Graaf IA; Groothuis GM
    Drug Metab Dispos; 2006 Nov; 34(11):1893-902. PubMed ID: 16914511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.